Oruka Therapeutics, Inc. Share Price
NASDAQ: ORKA | Mid CapOruka Therapeutics, Inc. Stock Performance
Open $94.75 | Prev. Close $96.37 | Circuit Range N/A |
Day Range $91.39 - $94.75 | Year Range $14.73 - $115.52 | Volume 35,762 |
Average Traded $92.80 |
Oruka Therapeutics, Inc. Share Price Today
As of 30 August 2026, Oruka Therapeutics, Inc.'s share price is $91.15. The stock opened at $94.75, compared to its previous close of $96.37. During today's trading session, Oruka Therapeutics, Inc.'s share price traded between $91.39 and $94.75, with an average price of $93.07. Over the past 52 weeks, the stock has recorded a high of $115.52 and a low of $14.73. In terms of performance, Oruka Therapeutics, Inc.'s share price has risen by 164.89% over the last six months and is up 516.09% on a year-on-year basis.
Oruka Therapeutics, Inc. Share Price Chart
Oruka Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $4.16B | PE Ratio (TTM) -49.27 | Dividend Yield N/A |
EPS (TTM) $-1.85 | Revenue (TTM) N/A | Return On Equity (TTM) -22.34% |
Profit Margin N/A | Debt to Equity 0.03 | Quarterly Earnings Growth YoY N/A |
Oruka Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Oruka Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 1 trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
Oruka Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $94.78 | $96.41 | -0.15% |
Jul 2026 | $94.76 | $96.55 | +1.44% |
Jun 2026 | $57.42 | $95.17 | +62.75% |
May 2026 | $68.50 | $58.48 | -14.79% |
Apr 2026 | $49.50 | $68.63 | +39.83% |
Mar 2026 | $33.70 | $49.08 | +42.63% |
Feb 2026 | $34.65 | $34.41 | +0.56% |
Jan 2026 | $30.35 | $34.22 | +12.77% |
Dec 2025 | $28.90 | $30.34 | +0.58% |
Nov 2025 | $27.39 | $30.17 | +7.18% |
Oct 2025 | $19.41 | $28.15 | +45.55% |
Sep 2025 | $14.85 | $19.34 | +30.72% |
ORKA Share Price FAQs
What is Oruka Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Oruka Therapeutics, Inc. stock?
What is ORKA's market capitalisation today?
What is ORKA's net income for the last quarter?
What is the 5 year returns of ORKA?
What is the high & low stock price of ORKA today?
Can I buy ORKA shares in India?